Trial Profile
A single centre, retrospective study of abatacept , tocilizumab and rituximab in patients with rheumatoid arthritis having past evidence of hepatitis B virus infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2017
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Rituximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 28 Aug 2017 Results published in the Clinical and Experimental Rheumatology
- 26 Aug 2016 New trial record